Related Experiment Video
Updated: Mar 28, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
The Effectiveness of Huangkui Lianchang Decoction Enema Solution Compared with Mesalazine Enema for Mild-to-Moderate
Yijia Zhu1,2, Rong Wang3, Haoyu Ding1,2
1The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, People's Republic of China.
Introduction:
Traditional Chinese medicine enemas have been widely utilized in clinical practice due to their rapid and effective relief of symptoms such as bloody stools and abdominal pain in ulcerative colitis (UC), sustained therapeutic effectiveness, and low cost. The objective of this multicenter, unblinded randomized controlled trial (RCT) is to evaluate whether the effectiveness and safety of HKE are comparable to those of Mesalazine enemas. Evidence from observational studies is of insufficient quality, underscoring the need for randomized controlled trials to strengthen the reliability and validity of the findings.
Methods And Analysis:
Eight hospitals in Jiangsu Province with Good Clinical Practice (GCP) certification will recruit patients with mild to moderate active rectal or left-sided colonic UC and randomly assign them in a 1:1 ratio to the Huangkui Lianchang decoction Enema (HKE) treatment group and the mesalazine enema treatment group. All participants received oral Mesalazine enteric-coated tablets. Enema treatment is administered for 8 weeks. Eighty-six patients are recruited for each group. Clinical events are monitored throughout the treatment and follow-up periods. The primary outcome is the modified Mayo score, assessed at baseline and post-treatment (on Day 56 ± 7). This score is used to evaluate both clinical outcomes (clinical remission and response rates) and endoscopic outcomes (endoscopic response and mucosal healing rates). Secondary outcomes include improvements in traditional Chinese medicine symptom scores, resolution rates of individual symptoms, endoscopic mucosal healing rates, and changes in C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and fecal calprotectin levels.
Discussion:
The outcomes of this research aim to provide evidence supporting the efficacy and safety of HKE enemas for treating ulcerative colitis, and generate high-quality evidence on the treatment of UC with Chinese herbal medicine retention enemas through rigorous clinical investigation. The findings are intended to inform the optimization of therapeutic strategies in clinical guidelines. As this study is a protocol, no results are available at this stage.
Trial Registration Number:
International Traditional Medicine Clinical Trial Registry ITMCTR2024000702 (https://itmctr.ccebtcm.org.cn/mgt/project/view/-7877458543771072185).
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...

